Skip to menu Skip to content Skip to footer

2024

Journal Article

Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer

Buteau, James P., Moon, Daniel, Fahey, Michael T., Roberts, Matthew J., Thompson, James, Murphy, Declan G., Papa, Nathan, Mitchell, Catherine, De Abreu Lourenco, Richard, Dhillon, Haryana M., Kasivisvanathan, Veeru, Francis, Roslyn J., Stricker, Phillip, Agrawal, Shihka, O'Brien, Jonathan, McVey, Aoife, Sharma, Gaurav, Levy, Sidney, Ayati, Narjess, Nguyen, Andrew, Lee, Su-Faye, Pattison, David A., Sivaratnam, Dinesh, Frydenberg, Mark, Du, Yang, Titus, Jehan, Lee, Sze-Ting, Ischia, Joseph, Jack, Greg ... Emmett, Louise (2024). Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer. European Urology Oncology, 7 (3), 544-552. doi: 10.1016/j.euo.2023.11.008

Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer

2024

Journal Article

Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more

Mehawed, Georges, Murray, Rebecca, Wang, Kevin, Roberts, Matthew J. and Rukin, Nicholas J. (2024). Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more. BJU International, 134 (S2), 14-16. doi: 10.1111/bju.16374

Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more

2024

Journal Article

What to do about recurrent urinary tract infections: A review of evidence behind emerging therapies

Wynn, Jessica, Homewood, David, Tse, Vincent, Fong, Eva, Roberts, Matthew J., Chung, Eric and Dowling, Caroline (2024). What to do about recurrent urinary tract infections: A review of evidence behind emerging therapies. Australian Journal of General Practice, 53 (5), 265-273. doi: 10.31128/AJGP-10-23-7004

What to do about recurrent urinary tract infections: A review of evidence behind emerging therapies

2024

Journal Article

Prostate tumour visualisation with PET: is image fusion with MRI the answer?

Mehawed, Georges, Murray, Rebecca, Rukin, Nicholas J. and Roberts, Matthew J. (2024). Prostate tumour visualisation with PET: is image fusion with MRI the answer?. BJU International, 133 (Supplement 4), 4-6. doi: 10.1111/bju.16335

Prostate tumour visualisation with PET: is image fusion with MRI the answer?

2024

Journal Article

Exploring unmet needs in prostate cancer care: a cross-sectional descriptive study

Roberts, Natasha A., Esler, Rachel, Pearce, Adam, Wyld, David, Smith, Michael, Woollett, Kaylene, Mazariego, Carolyn and Roberts, Matthew J. (2024). Exploring unmet needs in prostate cancer care: a cross-sectional descriptive study. European Urology Open Science, 62, 36-42. doi: 10.1016/j.euros.2024.01.018

Exploring unmet needs in prostate cancer care: a cross-sectional descriptive study

2024

Journal Article

Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?

Roberts, Matthew J., Yaxley, John W., Stranne, Johan, van Oort, Inge M. and Tilki, Derya (2024). Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?. Prostate Cancer and Prostatic Diseases, 1-3. doi: 10.1038/s41391-024-00821-3

Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?

2024

Journal Article

Cancer‐on‐chip and integrative tumor microenvironment sensor technologies for progressing precision radiotherapy

Dey, Shuvashis, Kinoshita, Masaki, Puttick, Simon, Rose, Stephen, Trau, Matt, Roberts, Matthew J. and Koo, Kevin M. (2024). Cancer‐on‐chip and integrative tumor microenvironment sensor technologies for progressing precision radiotherapy. Advanced Sensor Research, 3 (7) 2300193. doi: 10.1002/adsr.202300193

Cancer‐on‐chip and integrative tumor microenvironment sensor technologies for progressing precision radiotherapy

2024

Conference Publication

Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission

Vis, A., Meijer, D., Roberts, M.J., Siriwardana, A.R., Morton, A., Yaxley, J.W., Samaratunga, H., Emmett, L., Van Der Ven, P.M., Heymans, M.W., Nieuwenhuijzen, J.A., Van Der Poel, H.G., Van Donswijk, M.L., Boellaard, T.N., Schoots, I.G., Stricker, P., Haynes, A-M., Oprea-Lager, D.E., Coughlin, G.D. and Van Leeuwen, P.J. (2024). Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)00422-6

Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission

2024

Conference Publication

The early oncological effect of extended pelvic lymph node dissection in men with at PSMA PET/CT N0M0 intermediate/high-risk prostate cancer - an international cohort study

Van Leeuwen, P.J., Berrens, A-C., Vis, A., Yaxley, J., Meijer, D., Siriwardana, A., Wit, E., Van Der Noort, V., Morton, A., Franklin, A., Yaxley, J., Wong, D., Goughlin, G., Gianduzzo, T., Kua, B., Emmett, L., Zuur, L., Van Der Poel, H. and Roberts, M. (2024). The early oncological effect of extended pelvic lymph node dissection in men with at PSMA PET/CT N0M0 intermediate/high-risk prostate cancer - an international cohort study. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)01002-9

The early oncological effect of extended pelvic lymph node dissection in men with at PSMA PET/CT N0M0 intermediate/high-risk prostate cancer - an international cohort study

2024

Conference Publication

Early oncological outcomes following radical prostatectomy of patients with pelvic lymph node-positive prostate cancer at preoperative PSMA PET/CT

Zuur, L.G., de Bie, K., Vis, A.N., Van Der Poel, H.G., Donswijk, M.L., Oprea-Lager, D.E., Roberts, M. and Van Leeuwen, P.J. (2024). Early oncological outcomes following radical prostatectomy of patients with pelvic lymph node-positive prostate cancer at preoperative PSMA PET/CT. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)01187-4

Early oncological outcomes following radical prostatectomy of patients with pelvic lymph node-positive prostate cancer at preoperative PSMA PET/CT

2024

Conference Publication

Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer

Emmett, L., Papa, N., Hope, T., Fendler, W., Calais, J., Burger, I., Eiber, M., Barbato, F., Moon, D., Xue, A., Franklin, A., Thompson, J., Rasiah, K., Frydenberg, M., Yaxley, J., Buteau, J., Liu, V., Nguyen, A., Hsiao, E., Stricker, P., Hofman, M., Kasivisvanathan, V., Roberts, M. and Murphy, D. (2024). Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)00417-2

Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer

2024

Journal Article

The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis

Lindsay, Daniel, Schofield, Penelope, Nabukalu, Doreen, Roberts, Matthew J., Yaxley, John, Quinn, Stephen, Richards, Natalie, Frydenberg, Mark, Gardiner, Robert, Lawrentschuk, Nathan, Juraskova, Ilona, Murphy, Declan G. and Gordon, Louisa G. (2024). The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis. Australian Health Review, 48 (2), 172-181. doi: 10.1071/ah23231

The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis

2024

Journal Article

Intra‐individual comparison of prostate‐specific membrane antigen positron emission tomography/computed tomography versus bone scan in detecting skeletal metastasis at prostate cancer diagnosis

Shanmugasundaram, Ramesh, Saad, Jeremy, Heyworth, Ash, Wong, Veronica, Pelecanos, Anita, Arianayagam, Mohan, Canagasingham, Bertram, Ferguson, Richard, Goolam, Ahmed Saeed, Khadra, Mohamed, Kam, Jonathan, Ko, Raymond, McCombie, Stephen, Varol, Celi, Winter, Matthew, Mansberg, Robert, Nguyen, Diep, Bui, Chuong, Loh, Han, Le, Ken and Roberts, Matthew J. (2024). Intra‐individual comparison of prostate‐specific membrane antigen positron emission tomography/computed tomography versus bone scan in detecting skeletal metastasis at prostate cancer diagnosis. BJU International, 133 (S3), 25-32. doi: 10.1111/bju.16115

Intra‐individual comparison of prostate‐specific membrane antigen positron emission tomography/computed tomography versus bone scan in detecting skeletal metastasis at prostate cancer diagnosis

2024

Journal Article

Oncological Benefits of Extended Pelvic Lymph Node Dissection: More Fog or Clarity to the Debate?

Roberts, Matthew J., Cornford, Philip and Tilki, Derya (2024). Oncological Benefits of Extended Pelvic Lymph Node Dissection: More Fog or Clarity to the Debate?. European Urology, 87 (2), 261-263. doi: 10.1016/j.eururo.2024.12.001

Oncological Benefits of Extended Pelvic Lymph Node Dissection: More Fog or Clarity to the Debate?

2024

Journal Article

EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II—2024 update: treatment of relapsing and metastatic prostate cancer

Tilki, Derya, van den Bergh, Roderick C.N., Briers, Erik, Van den Broeck, Thomas, Brunckhorst, Oliver, Darraugh, Julie, Eberli, Daniel, De Meerleer, Gert, De Santis, Maria, Farolfi, Andrea, Gandaglia, Giorgio, Gillessen, Silke, Grivas, Nikolaos, Henry, Ann M., Lardas, Michael, J.L.H. van Leenders, Geert, Liew, Matthew, Linares Espinos, Estefania, Oldenburg, Jan, van Oort, Inge M., Oprea-Lager, Daniela E., Ploussard, Guillaume, Roberts, Matthew J., Rouvière, Olivier, Schoots, Ivo G., Schouten, Natasha, Smith, Emma J., Stranne, Johan, Wiegel, Thomas ... Cornford, Philip (2024). EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II—2024 update: treatment of relapsing and metastatic prostate cancer. European Urology, 86 (2), 164-182. doi: 10.1016/j.eururo.2024.04.010

EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II—2024 update: treatment of relapsing and metastatic prostate cancer

2024

Journal Article

The effect of three years of vitamin D supplementation on erectile dysfunction: results from the randomized placebo-controlled D-Health Trial

Romero, Briony Duarte, Waterhouse, Mary, Baxter, Catherine, McLeod, Donald S.A., English, Dallas R., Armstrong, Bruce K., Chung, Eric, Ebeling, Peter R., Hartel, Gunter, van der Pols, Jolieke C., Roberts, Matthew, Venn, Alison J., Webb, Penelope M., Whiteman, David C. and Neale, Rachel E. (2024). The effect of three years of vitamin D supplementation on erectile dysfunction: results from the randomized placebo-controlled D-Health Trial. Clinical Nutrition ESPEN, 60, 109-115. doi: 10.1016/j.clnesp.2024.01.011

The effect of three years of vitamin D supplementation on erectile dysfunction: results from the randomized placebo-controlled D-Health Trial

2024

Journal Article

The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer related pathology: A single centre retrospective study

Franklin, Anthony, Gianduzzo, Troy, Kua, Boon, Wong, David, McEwan, Louise, Walters, James, Esler, Rachel, Roberts, Matthew J., Coughlin, Geoff and Yaxley, John W. (2024). The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer related pathology: A single centre retrospective study. Asian Journal of Urology, 11 (1), 33-41. doi: 10.1016/j.ajur.2023.01.007

The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer related pathology: A single centre retrospective study

2024

Journal Article

Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment Histories

Aziz, Moez Karim, Molony, Donald, Monlezun, Dominique, Holder, Travis, Brunckhorst, Oliver, Higgason, Noel, Roland, Jerry, Magill, Resa, Fatakdawala, Mariya, Iacobucci, Alexander, Mody-Bailey, Neal, Owen, Chris, Zarker, Andrew, Thames, Emma, Swaby, Justin, Xiao, Daniel, Choi, Lily, Desai, Shubh, Galan, Jacob, Deng, Brett, Hartshorne, Taylor, Nichols, Alexis, Zhang, Allan, Imber, Jared, Song, Jeffrey, Jones, William, Rivas, Alexis, Sanchez, Darren, Guhan, Maya ... Canfield, Steven (2024). Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment Histories. European Urology, 87 (1), 15-26. doi: 10.1016/j.eururo.2024.08.031

Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment Histories

2024

Journal Article

Guidelines for genetic testing in prostate cancer: a scoping review

Tuffaha, Haitham, Edmunds, Kim, Fairbairn, David, Roberts, Matthew J., Chambers, Suzanne, Smith, David P, Horvath, Lisa, Arora, Shiksha and Scuffham, Paul (2024). Guidelines for genetic testing in prostate cancer: a scoping review. Prostate Cancer and Prostatic Diseases, 27 (4), 594-603. doi: 10.1038/s41391-023-00676-0

Guidelines for genetic testing in prostate cancer: a scoping review

2024

Journal Article

Reproducibility and accuracy of the PRIMARY score on PSMA PET and of PI-RADS on multiparametric MRI for prostate cancer diagnosis within a real-world database

Emmett, Louise, Papa, Nathan, Counter, William, Calais, Jeremie, Barbato, Francesco, Burger, Irene, Eiber, Matthias, Roberts, Matthew J., Agrawal, Shikha, Franklin, Anthony, Xue, Alan, Rasiah, Krishan, John, Nikeith, Moon, Daniel, Frydenberg, Mark, Yaxley, John, Stricker, Phillip, Wong, Keith, Coughlin, Geoff, Gianduzzo, Troy, Kua, Boon, Ho, Bao, Nguyen, Andrew, Liu, Victor, Lee, Jonathan, Hsiao, Edward, Sutherland, Tom, Perry, Elisa, Fendler, Wolfgang P. and Hope, Thomas A. (2024). Reproducibility and accuracy of the PRIMARY score on PSMA PET and of PI-RADS on multiparametric MRI for prostate cancer diagnosis within a real-world database. Journal of Nuclear Medicine, 65 (1), 94-99. doi: 10.2967/jnumed.123.266164

Reproducibility and accuracy of the PRIMARY score on PSMA PET and of PI-RADS on multiparametric MRI for prostate cancer diagnosis within a real-world database